Your session is about to expire
← Back to Search
Exercise Therapy for Cancer and COVID-19 Recovery
Phase 1
Waitlist Available
Led By Jessica Scott, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥ 18
If a female of child-bearing potential, must not be pregnant or planning to become pregnant during the study.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 weeks
Awards & highlights
Study Summary
This trial will evaluate the safety of an aerobic exercise therapy program for cancer patients recovering from COVID-19. The therapy being used is a walking program that will be adjusted to match participant fitness levels.
Who is the study for?
This trial is for adults over 18 who have had cancer, are recovering from COVID-19, and do less than 90 minutes of exercise a week. They must have space for a treadmill at home and be cleared to exercise. Women able to have children must not be pregnant or planning pregnancy during the study.Check my eligibility
What is being tested?
The trial tests a 30-week walking program tailored to fitness levels in cancer patients recovering from COVID-19. It aims to see if this aerobic exercise therapy is safe and causes few or mild side effects.See study design
What are the potential side effects?
Since the intervention involves aerobic exercise, potential side effects may include muscle soreness, fatigue, joint pain, or shortness of breath. However, these are expected to be mild as the program matches participant fitness levels.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am not pregnant nor planning to become pregnant during the study.
Select...
I was hospitalized due to Covid-19.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Frequency of serious adverse events during study-related assessments
Trial Design
1Treatment groups
Experimental Treatment
Group I: Participants who were hospitalized for COVID-19Experimental Treatment1 Intervention
Participants will be post-cancer treatment patients who were hospitalized for COVID-19.
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,940 Previous Clinical Trials
588,889 Total Patients Enrolled
Jessica Scott, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
6 Previous Clinical Trials
837 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am a woman under 50, can become pregnant, and have a recent negative pregnancy test.I am not pregnant nor planning to become pregnant during the study.It's been 1-10 years since I finished my primary cancer treatment, but I may still be on hormone therapy.You do less than 90 minutes of exercise that makes you breathe harder each week, based on what you tell the researchers.I was hospitalized due to Covid-19.You are currently receiving treatment for any other type of invasive cancer.I was discharged from the hospital more than 30 days ago.You have received treatment for cancer at MSK in the past.I have room for a treadmill at home.I am using oxygen at home after being discharged from the hospital.I am currently on a cancer treatment that does not involve hormone therapy.My cancer has spread to distant parts of my body.
Research Study Groups:
This trial has the following groups:- Group 1: Participants who were hospitalized for COVID-19
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger